Examining MOHN (Methylhydroxynandrolone): The Designer Steroid

Assessing Its Purported Effects and Questionable Real-World Viability

MOHN is an oral steroid intended to be a modified form of nandrolone with the addition of a 4-hydroxyl group. This aimed to increase potency and make it act more like trenbolone.

MOHN was designed to provide exceptional nitrogen retention and lean muscle building effects comparable to powerful injectables like trenbolone and Anavar according to its marketing.

However, human data is lacking as MOHN was never an approved prescription drug. Dosages ranged from 10-30 mg daily in cycles lasting 6-8 weeks typically.

While potent on paper, without human trials, MOHN’s real-world effects and safety profile remain speculative. Given its methylated structure, liver toxicity would also have been a considerable risk.

In summary, while intended as an optimized oral steroid, MOHN never gained official approval or lasting traction. With no verified performance data, safer known compounds have proven more reliable over the long run.